Key result
Comprehensive medical therapy and cardiac rehabilitation improve survival and quality of life in elderly CCS patients.
Why the study?
No current studies provide definitive conclusions on the comparison of PCI and coronary artery bypass grafting in elderly patients with ischemic heart disease.
In elderly patients with chronic coronary syndromes, optimal medical therapy, tailored shorter-duration antithrombotic regimens, and cardiac rehabilitation significantly improve survival, functional capacity, and quality of life.
Answers are grounded in this paper and cite their sources.
Supports guideline-endorsed medical therapy and rehabilitation in elderly CCS; leaves open need for RCTs to confirm survival benefits.
Drug therapy in elderly patients with chronic coronary syndromes significantly improves quality of life and survival, reducing the benefit of early invasive strategies. Myocardial revascularization through percutaneous coronary intervention (PCI) results in greater angina regression compared to placebo in patients with stable angina receiving conventional drug therapy. Current guidelines for chronic and stromal coronary syndromes favor relatively safe combinations of antiplatelet agents and allow for a shorter duration of dual antithrombotic therapy in patients aged 70–75 years and older. No current studies provide definitive conclusions on the comparison of PCI and coronary artery bypass grafting in elderly patients. Outpatient monitoring and cardiac rehabilitation provide significant benefits in the form of reduced mortality and morbidity, improved quality of life, reduced disease symptoms, increased functional capacity, and increased readiness for self-care in older patients with chronic coronary syndromes and a history of acute ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Барсуков et al. (2026) conducted a review in Ischemic heart disease / chronic coronary syndromes in elderly patients. Drug therapy, myocardial revascularization (PCI, CABG), antiplatelet therapy, and cardiac rehabilitation was evaluated on Quality of life, survival, angina regression, mortality, and morbidity. Drug therapy, tailored antiplatelet regimens, and cardiac rehabilitation improve survival and quality of life in elderly patients with chronic coronary syndromes (aged ≥70-75 years).
Synapse has enriched 10 related papers. Consider them for comparative context: